secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ovid Therapeutics Inc. (OVID)
CIK:        0001636651
Form:       8-K
Filed at:   2025-09-16T23:59:59+00:00
Accession:  0001193125-25-204308
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Ovid Therapeutics regains compliance with Nasdaq minimum bid price rule
-----------------------------------------------------------------------

- Received formal notice from Nasdaq on Sept 11, 2025, confirming compliance with Listing Rule 5550(a)(2).
- Minimum bid price had been below $1.00; company now meets the requirement.
- Nasdaq has closed the matter; no further action needed regarding listing status.
- Stock trading symbol OVID remains on The Nasdaq Stock Market LLC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636651/000119312525204308/0001193125-25-204308-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636651/000119312525204308/d80889d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-204308

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer